Table 2.

The Strategy Based on Cetuximab for Pancreatic Cancer

Treatment	Type of Pancreatic Cancer	Result	Status	Reference
Cetuximab+mild hyperthermia	PC	Reduced tumor volume	In vitro and animal experiment	[80]
Cetuximab+IL-21	PC	Inhibited tumor growth significantly	In vitro and animal experiment	[81]
64-bit Cu-labeled cetuximab	PC	Prolonged the survival rate	In vitro and animal experiment	[82]
Cetuximab+Neuropilin-1	PDAC	Inhibited the growth of PDAC cells and overcame drug resistance	In vitro and animal experiment	[83]
Cetuximab+NVP-LDE225	PDAC	Inhibited tumor growth	In vitro and animal experiment	[84]